Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...

Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...

The breach was one of the largest reported cyberattack in insurance, as Allianz Life has around 1.4 million customers in the ...

Arena International has announced the launch of the GlobalData Automotive Europe Conference 2025, set to take place ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

Greater China emerges as key player, driven by Hong Kong’s resurgence and "shifting global capital flows toward Chinese ...

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

The global IPO market displayed resilience in the first seven months of 2025, with proceeds rising 9.5% YoY to $56.8 billion: ...